Many school cafeterias have students on work / study working in the cafeteria and this can make training about food allergies and
EpiPens more difficult.
In fact, prior to the recent price hike backlash, Mylan was looking to make
the EpiPen more expensive.
Not exact matches
Mylan drew major flak last year after news broke that it had steadily increased the list price for an
EpiPen two - pack from about $ 100 to
more than $ 600 in less than a decade.
Noting that the actual rebate should have been at least 10 percentage points higher, Wyden and Pallone said, «Today's letter is
more evidence that while Mylan irresponsibly raised the price of
EpiPen, they were also bilking taxpayers out of millions of dollars.»
For
more on Bresch, read Fortune's 2015 feature, «Why Wall Street Loves to Hate Mylan's CEO» and «Why the CEO Behind the
EpiPen Controversy Remains One of Fortune's Most Powerful Women.»
Mylan, one of the 10 most heavily weighted stocks in the ETF, traded
more than 1.5 percent higher despite recent political pressure over the stark price increases of its life - saving
EpiPen device.
Its brand has become synonymous with Kleenex and other household products when it comes to fighting deadly allergies; in fact, the
EpiPen enjoys a near - monopoly on the market with annual sales of
more than $ 1.3 billion and nearly 90 % U.S. market share in the space.
She poured marketing resources into the product, and embarked on an awareness and political campaign to get
more EpiPens into schools and other public institutions.
Mylan has raised the price for the
EpiPen, an auto - injector device that delivers epinephrine to counteract deadly allergic reactions which must be replaced on a yearly basis,
more than 400 % over the last decade, putting families who have high deductible health insurance in a bind.
Under Mylan, sales of
EpiPen grew at an average annual rate of 33 %,
more than doubling their 13 % annualized growth rate before Bresch took charge.
In total, that amounts to a
more than six-fold increase in the wholesale price of
EpiPen since Mylan bought it.
She said that employers» increased use of high - deductible plans, one of the side - effects of the law, has resulted in patients paying
more out of pocket for the drug, and that's «where you're seeing a lot of noise around
EpiPen.»
What's
more, Bresch, citing the roughly $ 600 wholesale cost, added that when you look at other treatments, the
EpiPen does not fall into the category of «an expensive product.»
A lot of that growth came from increasing
EpiPen prescriptions as the product became
more mainstream: In the first seven years Mylan owned
EpiPen, the number of patients using it grew 67 %, according to Bloomberg.
Pharmaceutical giant Mylan was embroiled in a controversy about its drug pricing last year when it hiked the price of
EpiPen by
more than 400 percent.
A group of midlevel executives was concerned about the soaring price of
EpiPens, which had
more than doubled in the previous four years; there were rumors that even
more aggressive hikes were planned.
She added that Mylan had responded promptly when the Food and Drug Administration criticized the company's advertisement in 2012, and that the
EpiPen had become
more expensive because Mylan had invested in public awareness and improving the device.
Chicago Public Schools is simultaneously increasing its awareness of the dangers of severe allergies and stocking
more of the
EpiPen shots used to treat them this academic year.
EpiPens are... read
more...
More than 460 agencies statewide are participating in the Check & Inject NY training program to use syringes rather than the
EpiPens.
Canonsburg, Pennsylvania - based Mylan N.V. said Tuesday that
more than 700,000 free
EpiPens have been distributed to 65,000 schools and it has dropped a previous purchase restriction for schools that wanted
more at discounts.
Congress is calling for
more information on why the price of
EpiPens is climbing.
«Given the recent unconscionable price increases of
EpiPens by Mylan Pharmaceutical, we must look to
more affordable alternatives for families dealing with allergies,» Hannon said in a statement.
There's another advantage to the DIY approach, too, at least for a trained professional: While
EpiPens are only available in two doses, a syringe allows for customized doses — less for small children and
more for larger, heavier adults, for example.
Even if a doctor or pharmacist labels it and includes prescription information, the process would be
more daunting for a typical bystander than the practically foolproof
EpiPen.
Epinephrine can also be easily damaged by light and heat, so a DIY kit would have to be prepared and carried very carefully, and refilled
more often than an
EpiPen, in order to make sure the medicine doesn't become ineffective.
Now we know exactly how outrageous it is: The price of the
EpiPen — an auto - injector of the inexpensive hormone ephinephrine — has skyrocketed by
more than 600 % since 2008, Money reports, from around $ 100 for the standard two - pack in 2008 to
more than $ 735 today.
Coverage for the
EpiPen under these carriers will be the most favorable, with lower copays and
more available coverage.